Hakan Paydak
Concepts (234)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 24 | 2022 | 180 | 5.520 |
Why?
| Defibrillators, Implantable | 10 | 2019 | 60 | 2.890 |
Why?
| Anti-Arrhythmia Agents | 8 | 2020 | 79 | 2.360 |
Why?
| Electrocardiography | 11 | 2021 | 257 | 2.320 |
Why?
| Catheter Ablation | 10 | 2018 | 123 | 2.150 |
Why?
| Arrhythmias, Cardiac | 5 | 2020 | 95 | 1.880 |
Why?
| Tachycardia, Supraventricular | 3 | 2021 | 40 | 1.820 |
Why?
| Hospitalization | 7 | 2022 | 652 | 1.580 |
Why?
| Tachycardia | 3 | 2021 | 29 | 1.250 |
Why?
| Amiodarone | 3 | 2017 | 22 | 1.130 |
Why?
| Pacemaker, Artificial | 4 | 2019 | 34 | 1.010 |
Why?
| Heart Rate | 4 | 2021 | 293 | 0.980 |
Why?
| Vena Cava, Superior | 2 | 2015 | 22 | 0.900 |
Why?
| Anticoagulants | 5 | 2019 | 250 | 0.840 |
Why?
| Humans | 58 | 2023 | 49974 | 0.820 |
Why?
| Tachycardia, Ventricular | 5 | 2020 | 44 | 0.790 |
Why?
| Cardiomyopathy, Dilated | 1 | 2020 | 35 | 0.720 |
Why?
| Hospital Mortality | 5 | 2017 | 409 | 0.720 |
Why?
| Echocardiography, Transesophageal | 1 | 2020 | 60 | 0.710 |
Why?
| Middle Aged | 22 | 2020 | 12069 | 0.700 |
Why?
| Metoprolol | 1 | 2019 | 13 | 0.660 |
Why?
| Warfarin | 3 | 2019 | 86 | 0.650 |
Why?
| Male | 33 | 2022 | 25241 | 0.650 |
Why?
| Syncope | 2 | 2013 | 28 | 0.640 |
Why?
| Bundle-Branch Block | 2 | 2012 | 10 | 0.630 |
Why?
| Heart Failure | 3 | 2019 | 458 | 0.610 |
Why?
| Heparin | 2 | 2016 | 92 | 0.610 |
Why?
| Treatment Outcome | 14 | 2022 | 5141 | 0.600 |
Why?
| Lung Diseases, Interstitial | 1 | 2017 | 23 | 0.580 |
Why?
| Length of Stay | 4 | 2015 | 619 | 0.570 |
Why?
| Hemothorax | 1 | 2016 | 4 | 0.570 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 35 | 0.560 |
Why?
| Heart Conduction System | 2 | 2015 | 24 | 0.560 |
Why?
| Cost of Illness | 2 | 2015 | 117 | 0.560 |
Why?
| Prosthesis Implantation | 1 | 2016 | 44 | 0.550 |
Why?
| Pneumonia | 1 | 2017 | 118 | 0.540 |
Why?
| Wolff-Parkinson-White Syndrome | 1 | 2016 | 7 | 0.540 |
Why?
| Torsades de Pointes | 3 | 2014 | 15 | 0.540 |
Why?
| Propafenone | 1 | 2015 | 2 | 0.520 |
Why?
| Tachycardia, Ectopic Atrial | 1 | 2015 | 3 | 0.520 |
Why?
| Flecainide | 1 | 2015 | 5 | 0.520 |
Why?
| Accessory Atrioventricular Bundle | 1 | 2014 | 3 | 0.500 |
Why?
| Propofol | 1 | 2015 | 21 | 0.500 |
Why?
| Heart Ventricles | 4 | 2015 | 249 | 0.490 |
Why?
| Mucolipidoses | 1 | 2014 | 4 | 0.490 |
Why?
| Postoperative Hemorrhage | 1 | 2015 | 51 | 0.490 |
Why?
| Hospital Costs | 1 | 2015 | 71 | 0.490 |
Why?
| Exercise Test | 1 | 2015 | 121 | 0.490 |
Why?
| Ventricular Dysfunction, Left | 2 | 2015 | 91 | 0.490 |
Why?
| Electric Countershock | 4 | 2022 | 30 | 0.480 |
Why?
| Female | 24 | 2022 | 26472 | 0.480 |
Why?
| Hyponatremia | 1 | 2013 | 11 | 0.460 |
Why?
| Takotsubo Cardiomyopathy | 1 | 2013 | 20 | 0.450 |
Why?
| Theophylline | 1 | 2013 | 19 | 0.440 |
Why?
| Patient Safety | 1 | 2014 | 102 | 0.440 |
Why?
| Therapy, Computer-Assisted | 1 | 2013 | 30 | 0.440 |
Why?
| Health Care Costs | 1 | 2014 | 170 | 0.440 |
Why?
| Vascular Malformations | 1 | 2015 | 98 | 0.430 |
Why?
| Seasons | 1 | 2013 | 81 | 0.430 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 5 | 0.420 |
Why?
| Azygos Vein | 1 | 2012 | 11 | 0.420 |
Why?
| Coronary Sinus | 1 | 2012 | 4 | 0.420 |
Why?
| Electrodes, Implanted | 1 | 2012 | 30 | 0.420 |
Why?
| Heart Block | 2 | 2009 | 26 | 0.420 |
Why?
| Superior Vena Cava Syndrome | 1 | 2012 | 11 | 0.410 |
Why?
| Foreign-Body Migration | 1 | 2012 | 32 | 0.410 |
Why?
| Heart Diseases | 1 | 2014 | 206 | 0.410 |
Why?
| Cardiac Pacing, Artificial | 1 | 2012 | 28 | 0.400 |
Why?
| Vena Cava, Inferior | 1 | 2012 | 79 | 0.400 |
Why?
| Catheters, Indwelling | 1 | 2012 | 58 | 0.400 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 31 | 0.400 |
Why?
| Postoperative Complications | 2 | 2014 | 984 | 0.390 |
Why?
| Adult | 15 | 2022 | 13236 | 0.390 |
Why?
| Aged | 18 | 2022 | 9310 | 0.390 |
Why?
| Sinoatrial Node | 1 | 2011 | 3 | 0.390 |
Why?
| Catheterization, Central Venous | 1 | 2012 | 86 | 0.380 |
Why?
| Incidence | 4 | 2019 | 1003 | 0.350 |
Why?
| Retrospective Studies | 10 | 2023 | 6108 | 0.350 |
Why?
| Head and Neck Neoplasms | 1 | 2013 | 268 | 0.350 |
Why?
| Stroke | 3 | 2022 | 492 | 0.340 |
Why?
| Diagnosis, Differential | 5 | 2019 | 1037 | 0.330 |
Why?
| Haloperidol | 1 | 2009 | 46 | 0.330 |
Why?
| Magnetic Resonance Imaging | 2 | 2017 | 1537 | 0.320 |
Why?
| Aged, 80 and over | 7 | 2019 | 3129 | 0.300 |
Why?
| Antipsychotic Agents | 1 | 2009 | 232 | 0.280 |
Why?
| Multiple Myeloma | 3 | 2017 | 2929 | 0.280 |
Why?
| Hypertension | 4 | 2019 | 533 | 0.270 |
Why?
| Risk Factors | 7 | 2019 | 3613 | 0.260 |
Why?
| Reproducibility of Results | 3 | 2015 | 1193 | 0.250 |
Why?
| Survival Rate | 2 | 2019 | 894 | 0.240 |
Why?
| Obesity | 1 | 2012 | 1113 | 0.230 |
Why?
| Time Factors | 7 | 2019 | 2903 | 0.220 |
Why?
| Body Surface Potential Mapping | 1 | 2003 | 1 | 0.220 |
Why?
| Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.220 |
Why?
| Young Adult | 5 | 2017 | 3958 | 0.220 |
Why?
| Adolescent | 6 | 2017 | 6356 | 0.220 |
Why?
| Databases, Factual | 6 | 2017 | 658 | 0.220 |
Why?
| Arkansas | 3 | 2019 | 1977 | 0.210 |
Why?
| Follow-Up Studies | 3 | 2019 | 2182 | 0.210 |
Why?
| Vagus Nerve Stimulation | 1 | 2022 | 11 | 0.200 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 138 | 0.200 |
Why?
| Blood Flow Velocity | 1 | 2001 | 101 | 0.200 |
Why?
| Disease Management | 2 | 2020 | 174 | 0.190 |
Why?
| Telemetry | 1 | 2021 | 32 | 0.190 |
Why?
| Pericardial Effusion | 1 | 2001 | 43 | 0.190 |
Why?
| Sleep Apnea, Obstructive | 1 | 2001 | 67 | 0.190 |
Why?
| Syndrome | 3 | 2015 | 237 | 0.180 |
Why?
| Heart Arrest | 1 | 2022 | 149 | 0.180 |
Why?
| Sick Sinus Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
| Hypoventilation | 1 | 2019 | 3 | 0.170 |
Why?
| Sleep Apnea, Central | 1 | 2019 | 12 | 0.170 |
Why?
| Recovery of Function | 1 | 2020 | 188 | 0.170 |
Why?
| Hyperlipidemias | 1 | 2019 | 49 | 0.170 |
Why?
| Diaphragm | 1 | 2019 | 29 | 0.170 |
Why?
| Antithrombins | 1 | 2019 | 19 | 0.170 |
Why?
| Artifacts | 1 | 2019 | 53 | 0.170 |
Why?
| Echocardiography | 3 | 2017 | 378 | 0.160 |
Why?
| Diabetes Complications | 1 | 2019 | 118 | 0.160 |
Why?
| Heart Injuries | 1 | 2018 | 15 | 0.160 |
Why?
| Cardiac Surgical Procedures | 1 | 2022 | 297 | 0.160 |
Why?
| Atrial Flutter | 1 | 1998 | 8 | 0.160 |
Why?
| Death, Sudden, Cardiac | 1 | 2019 | 53 | 0.160 |
Why?
| Fatty Acids, Omega-3 | 1 | 2018 | 28 | 0.160 |
Why?
| United States | 5 | 2016 | 4860 | 0.160 |
Why?
| Vascular System Injuries | 1 | 2018 | 36 | 0.160 |
Why?
| Cardiotonic Agents | 1 | 2018 | 66 | 0.160 |
Why?
| Adrenergic beta-Antagonists | 1 | 2019 | 102 | 0.160 |
Why?
| Cause of Death | 1 | 2019 | 143 | 0.150 |
Why?
| Seizures | 2 | 2022 | 195 | 0.150 |
Why?
| Ventricular Function, Left | 1 | 2019 | 154 | 0.150 |
Why?
| Brain Ischemia | 1 | 2019 | 161 | 0.150 |
Why?
| Comorbidity | 3 | 2014 | 615 | 0.150 |
Why?
| Hemorrhage | 2 | 2019 | 197 | 0.150 |
Why?
| Anti-Inflammatory Agents | 1 | 2018 | 161 | 0.150 |
Why?
| Prednisone | 1 | 2017 | 99 | 0.140 |
Why?
| Coronary Vessels | 1 | 2018 | 152 | 0.140 |
Why?
| Accidents, Traffic | 1 | 2017 | 88 | 0.140 |
Why?
| Heart Atria | 3 | 2012 | 55 | 0.140 |
Why?
| Ventricular Fibrillation | 2 | 2009 | 16 | 0.140 |
Why?
| Clinical Trials as Topic | 3 | 2018 | 461 | 0.140 |
Why?
| Administration, Oral | 2 | 2019 | 426 | 0.140 |
Why?
| Maternal Exposure | 1 | 2017 | 86 | 0.140 |
Why?
| Perioperative Period | 1 | 2016 | 22 | 0.140 |
Why?
| Odds Ratio | 2 | 2015 | 545 | 0.140 |
Why?
| Radiography, Thoracic | 1 | 2016 | 65 | 0.140 |
Why?
| Sex Factors | 2 | 2016 | 691 | 0.140 |
Why?
| Voltage-Gated Sodium Channel Blockers | 1 | 2015 | 5 | 0.130 |
Why?
| Ventricular Function | 1 | 2015 | 18 | 0.130 |
Why?
| Glucocorticoids | 1 | 2017 | 219 | 0.130 |
Why?
| Vitamin K | 1 | 2015 | 16 | 0.130 |
Why?
| Age Factors | 2 | 2015 | 1087 | 0.130 |
Why?
| Anesthetics, Intravenous | 1 | 2015 | 24 | 0.130 |
Why?
| Insurance, Health | 1 | 2016 | 126 | 0.120 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2015 | 549 | 0.120 |
Why?
| Infusions, Intravenous | 1 | 2015 | 206 | 0.120 |
Why?
| Forecasting | 1 | 2015 | 150 | 0.120 |
Why?
| Health Planning | 1 | 2014 | 13 | 0.120 |
Why?
| Thromboembolism | 1 | 2015 | 54 | 0.120 |
Why?
| Fatal Outcome | 1 | 2015 | 195 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 274 | 0.120 |
Why?
| Hematologic Neoplasms | 1 | 2015 | 99 | 0.120 |
Why?
| Cardiomyopathies | 1 | 2015 | 108 | 0.120 |
Why?
| Fibrinolytic Agents | 1 | 2015 | 124 | 0.120 |
Why?
| Methadone | 1 | 2014 | 172 | 0.110 |
Why?
| Radiography | 1 | 2015 | 489 | 0.110 |
Why?
| Ultrasonography | 2 | 2012 | 436 | 0.110 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2013 | 48 | 0.110 |
Why?
| Healthcare Disparities | 1 | 2016 | 257 | 0.110 |
Why?
| Vasodilator Agents | 1 | 2013 | 96 | 0.110 |
Why?
| Health Care Surveys | 1 | 2013 | 173 | 0.100 |
Why?
| Bradycardia | 1 | 2012 | 36 | 0.100 |
Why?
| Cardiovascular Diseases | 1 | 2017 | 440 | 0.100 |
Why?
| After-Hours Care | 1 | 2012 | 11 | 0.100 |
Why?
| Angioplasty | 1 | 2012 | 20 | 0.100 |
Why?
| Prevalence | 1 | 2015 | 944 | 0.100 |
Why?
| Mitral Valve | 1 | 2012 | 49 | 0.100 |
Why?
| Angiography | 1 | 2012 | 126 | 0.100 |
Why?
| Phlebography | 1 | 2012 | 61 | 0.100 |
Why?
| Patient Admission | 1 | 2012 | 77 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2015 | 945 | 0.100 |
Why?
| Device Removal | 1 | 2012 | 85 | 0.100 |
Why?
| Disease Progression | 1 | 2014 | 825 | 0.100 |
Why?
| Subarachnoid Hemorrhage | 1 | 2012 | 65 | 0.100 |
Why?
| Stem Cell Transplantation | 1 | 2012 | 181 | 0.100 |
Why?
| Hospitals | 2 | 2023 | 175 | 0.090 |
Why?
| Patient Discharge | 1 | 2013 | 320 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 861 | 0.090 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 565 | 0.090 |
Why?
| Dextrocardia | 1 | 2009 | 4 | 0.090 |
Why?
| Pregnancy | 1 | 2017 | 2607 | 0.080 |
Why?
| Algorithms | 1 | 2013 | 615 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2014 | 1557 | 0.080 |
Why?
| Cardiac Catheterization | 1 | 2009 | 201 | 0.070 |
Why?
| Kidney Failure, Chronic | 1 | 2009 | 198 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2012 | 1159 | 0.070 |
Why?
| Inpatients | 2 | 2022 | 190 | 0.070 |
Why?
| Magnetics | 1 | 2003 | 39 | 0.050 |
Why?
| Vagus Nerve | 1 | 2022 | 23 | 0.050 |
Why?
| Electrodes | 1 | 2022 | 36 | 0.050 |
Why?
| False Negative Reactions | 1 | 2001 | 30 | 0.050 |
Why?
| Echocardiography, Doppler | 1 | 2001 | 53 | 0.050 |
Why?
| Animals | 2 | 2018 | 13187 | 0.050 |
Why?
| Ambulances | 1 | 1999 | 8 | 0.040 |
Why?
| Equipment Failure Analysis | 1 | 1999 | 46 | 0.040 |
Why?
| Logistic Models | 2 | 2012 | 888 | 0.040 |
Why?
| Arthralgia | 1 | 1999 | 43 | 0.040 |
Why?
| Shoulder Joint | 1 | 1999 | 38 | 0.040 |
Why?
| Drug Utilization | 1 | 2019 | 77 | 0.040 |
Why?
| Motor Vehicles | 1 | 2017 | 15 | 0.040 |
Why?
| Recurrence | 1 | 1998 | 652 | 0.030 |
Why?
| Databases, Bibliographic | 1 | 2016 | 15 | 0.030 |
Why?
| Heparin, Low-Molecular-Weight | 1 | 2016 | 20 | 0.030 |
Why?
| Medically Uninsured | 1 | 2016 | 45 | 0.030 |
Why?
| Heart | 1 | 2017 | 326 | 0.030 |
Why?
| Safety | 1 | 2015 | 78 | 0.030 |
Why?
| Risk | 1 | 2015 | 320 | 0.030 |
Why?
| Age Distribution | 1 | 2013 | 168 | 0.030 |
Why?
| Systole | 1 | 2012 | 68 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2013 | 903 | 0.020 |
Why?
| Transplantation, Autologous | 1 | 2012 | 466 | 0.020 |
Why?
| Child | 1 | 2003 | 6847 | 0.020 |
Why?
| Kidney Diseases | 1 | 2012 | 214 | 0.020 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 381 | 0.020 |
Why?
| Situs Inversus | 1 | 2009 | 3 | 0.020 |
Why?
| Prospective Studies | 1 | 2015 | 2364 | 0.020 |
Why?
| Kidney | 1 | 2012 | 665 | 0.020 |
Why?
| Risk Assessment | 1 | 2012 | 1259 | 0.020 |
Why?
| Coronary Angiography | 1 | 2009 | 334 | 0.020 |
Why?
| Pectoralis Muscles | 1 | 1999 | 6 | 0.010 |
Why?
| Transportation of Patients | 1 | 1999 | 38 | 0.010 |
Why?
| Physical Therapy Modalities | 1 | 1999 | 36 | 0.010 |
Why?
| Range of Motion, Articular | 1 | 1999 | 108 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 1999 | 637 | 0.010 |
Why?
| Software | 1 | 1999 | 273 | 0.010 |
Why?
|
|
Paydak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|